- Inicio
- Publicaciones
- Pregnancy Control in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Part 1: Infertility, Ovarian Preservation and Preconception Assessment. Consensus Document of the Spanish Society of Gynaecology and Obstetrics (SEGO), the Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Rheumatology (SER).
Pregnancy Control in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Part 1: Infertility, Ovarian Preservation and Preconception Assessment. Consensus Document of the Spanish Society of Gynaecology and Obstetrics (SEGO), the Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Rheumatology (SER).
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Espinosa G
- Galindo-Izquierdo M
- Casellas Caro M
- Delgado Beltrán P
- Martínez López JA
- Martínez Sánchez N
- Robles-Marhuenda A
- Rodríguez Almaraz E
- Sáez-Comet L
- Ugarte A
- Vela-Casasempere P
- Bartha JL
- Ruiz-Irastorza G
- Martínez-Taboada VM
Abstract
Pregnancy and puerperium are considered a risk situation in women with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). Therefore, specialized assessment is essential both preconception and during pregnancy and the puerperium. Likewise, it is very important that different specialists in autoimmune diseases and high-risk pregnancies participate in the follow-up of these patients in a coordinated manner. The Spanish Society of Gynaecology and Obstetrics, the Spanish Society of Internal Medicine, and the Spanish Society of Rheumatology have set up a working group for the preparation of three consensus documents.
Datos de la publicación
- ISSN/ISSNe:
- 1699-258X, 1885-1398
- Tipo:
- Article
- Páginas:
- 61-66
- Factor de Impacto:
- 0,256 SCImago ℠
- Cuartil:
- Q4 SCImago ℠
Reumatologia Clinica ELSEVIER DOYMA SL
Citas Recibidas en Web of Science: 5
Documentos
- No hay documentos
Filiaciones
Keywords
- Anticoncepción, Antiphospholipid syndrome, Contraception, Embarazo, Lactancia, Lactation, Lupus eritematoso sistémico, Pregnancy, Puerperio, Puerperium, Systemic lupus erythematosus, Síndrome antifosfolípido
Proyectos asociados
PAPEL DEL FACTOR DE CRECIMIENTO PLACENTARIO EN EL MANEJO DE LA PREECLAMPSIA NO SEVERA: ESTUDIO ALEATORIZADO
Investigador Principal: ALFREDO JOSÉ PERALES MARÍN
PI15/01935 . INSTITUTO DE SALUD CARLOS III . 2016
UN ESTUDIO DE PRUEBA DE CONCEPTO DE FASE 2A, DOBLE CIEGO, DE GRUPO PARALELO ALEATORIZADO Y CONTROLADO CON PLACEBO QUE EVALÚA LA EFICACIA, LA SEGURIDAD Y LA FARMACOCINÉTICA DE OBE022 COMBINADO CON ATOSIBAN TRAS SU ADMINISTRACIÓN POR VÍA ORAL A MUJERES EMBARAZADAS CON AMENAZA DE PARTO PREMATURO.
Investigador Principal: ALFREDO JOSÉ PERALES MARÍN
17-OBE022-003 . 2018
ESTUDIO DE FASE IIB/IIIA, MULTICÉNTRICO, ALEATORIZADO, DE GRUPOS PARALELOS, CON ENMASCARAMIENTO DOBLE Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE AMAG-423, UN FRAGMENTO AB DE ANTICUERPOS ANTIDIGOXINA, EN PACIENTES EMBARAZADAS CON PREECLAMPSIA GRAVE.
Investigador Principal: ALFREDO JOSÉ PERALES MARÍN
AMAG-423-201 . 2019
Cita
Espinosa G,Galindo M,Marcos B,Casellas M,Delgado P,Martínez JA,Martínez N,Robles A,Rodríguez E,Sáez L,Ugarte A,Vela P,Bartha JL,Ruiz G,Martínez VM. Pregnancy Control in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Part 1: Infertility, Ovarian Preservation and Preconception Assessment. Consensus Document of the Spanish Society of Gynaecology and Obstetrics (SEGO), the Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Rheumatology (SER). Reumatol. Clin. 2019. 17. (2):p. 61-66.